Skip to Content

SPD465 Approval Status

  • FDA approved: No
  • Brand name: SPD465
  • Generic name: triple-bead mixed amphetamine salts
  • Company: Shire plc
  • Treatment for: ADHD in Adults

SPD465 an investigational oral stimulant intended to provide symptom control of ADHD in adults.

Development Status and FDA Approval Process for SPD465

May 21, 2007FDA Issues Approvable Letter for SPD465 (Triple-Bead Mixed Amphetamine Salts) for the Treatment of ADHD in Adults
Jul 21, 2006Shire Announces Filing of SPD465 for the Treatment of Adult ADHD

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.